Literature DB >> 1985795

AIDS virus infection and autoimmunity: a perspective of the clinical, immunological, and molecular origins of the autoallergic pathologies associated with HIV disease.

W J Morrow1, D A Isenberg, R E Sobol, R B Stricker, T Kieber-Emmons.   

Abstract

The acquired immune deficiency syndrome (AIDS) is a viral-induced disorder of humans that is reaching pandemic proportions. The etiologic agent responsible for AIDS is recognized as a retrovirus termed the human immunodeficiency virus (HIV). This virus is both cytotropic and cytopathic for T lymphocytes in vitro, and patients with AIDS and HIV-related conditions invariably have serious T cell abnormalities, notably a reduced number of the helper/inducer (CD4+) subpopulation. There is now a substantial body of evidence to suggest that the AIDS virus triggers a diverse range of autoimmune phenomena. The purpose of this article is to summarize the clinical and immunopathological manifestations of autoimmunity in HIV infection and to provide a perspective of the possible origins and roles autoimmune reactions play in HIV disease progression.

Entities:  

Mesh:

Year:  1991        PMID: 1985795     DOI: 10.1016/0090-1229(91)90134-v

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  22 in total

1.  A gp120 HIV peptide with high similarity to HLA class II beta chains enhances PPD-specific and autoreactive T cell activation.

Authors:  O Pugliese; M Viora; B Camponeschi; P Cordiali Fei; F Caprilli; A Chersi; M Evangelista; A M Di Massimo; V Colizzi
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

2.  Autoimmune phenomena and activation of the immune system in HIV infection.

Authors:  M Radkowski; E Kaminska; T Laskus
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

Review 3.  Molecular immunopathogenesis of HIV infection.

Authors:  T T Ng; A J Pinching; C Guntermann; W J Morrow
Journal:  Genitourin Med       Date:  1996-12

4.  Serum antibodies to HIV-1 are produced post-measles virus infection: evidence for cross-reactivity with HLA.

Authors:  P V Baskar; G D Collins; B A Dorsey-Cooper; R S Pyle; J E Nagel; D Dwyer; G Dunston; C E Johnson; N Kendig; E Israel; D R Nalin; W H Adler
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

Review 5.  New approaches to HIV vaccine development.

Authors:  Barton F Haynes
Journal:  Curr Opin Immunol       Date:  2015-06-08       Impact factor: 7.486

6.  Relationship of antibodies against CD4+ T cells in HIV-infected patients to markers of activation and progression: autoantibodies are closely associated with CD4 cell depletion.

Authors:  C Müller; S Kukel; R Bauer
Journal:  Immunology       Date:  1993-06       Impact factor: 7.397

Review 7.  HIV-mediated B-lymphocyte activation and lymphomagenesis.

Authors:  J G Monroe; L E Silberstein
Journal:  J Clin Immunol       Date:  1995-03       Impact factor: 8.317

Review 8.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

9.  Anti-lymphocyte antibodies in plasma of HIV-1-infected patients preferentially react with MHC class II-negative T cells and are linked to antibodies against gp41.

Authors:  C Müller; S Kukel; K E Schneweis; R Bauer
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

10.  IgA from HIV+ haemophilic patients triggers intracellular signals coupled to the cholinergic system of the intestine.

Authors:  M E Sales; L Sterin-Borda; M M de Bracco; M Rodriguez; M Narbaitz; E Borda
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.